Bioimpedance based biomarker for the detection of precancerous and cancerous lesions of the pancreas: feasibility animal study

Author:

Dibennardo Federica,Fidaner Onur,Bogdanowicz Les,Gehrke Daniel S.,Ceres Donato,John Margaret C.,Bovalis Constantine H.,Kundro Erik M.,Grycuk Alexander,Castellanos Karla,Coleman Adonis,Sudhir Kavya,Heneche Jorge,Acebedo Jose,Jimenez Angel,Raijman Isaac,Grippo Paul,Guidetti MartinaORCID

Abstract

Abstract Background Pancreatic cancer (PC) remains a significant healthcare challenge due to its aggressive nature and poor prognosis. The current gold standard that combines imaging modalities, endoscopy, and biopsies has limited diagnostic efficacy due to various shortcomings. Methods We propose a feasibility study for the use of a bioimpedance biomarker to detect PC. The biomarker was evaluated in a double blind study on ex vivo pancreata of mice: 15 LSL-KrasG12D; LSL-p53R172H; Pdx1-Cre, 2 LSL-KrasG12D, and 9 wild type controls (Study 1). To determine if the biomarker can distinguish between PC and acute pancreatitis (AP), we challenged it with 18 cerulein-induced AP and 6 saline-injected controls (Study 2). Results The results from Study 1 showed 100% specificity and 94% sensitivity against histopathology outcomes; for Study 2 all AP and saline-injected pancreases were diagnosed as non-cancerous. Regression analysis revealed a positive correlation between biomarker and pathologically analyzed cancer-induced fibrosis (r(24)= 0.73 (p<0.001)). Conclusion These findings demonstrate the potential of this bioimpedance biomarker as a diagnostic tool for PC.

Publisher

Springer Science and Business Media LLC

Reference57 articles.

1. Globocan PS. Pancreas Statistics Globocan 2020 | WHO. 2020. https://gco.iarc.fr/today/data/factsheets/cancers/13-Pancreas-fact-sheet.pdf. Accessed 24 Nov 2023.

2. CancerStatisticsCenter. Analysis Tool | American Cancer Society - Cancer Facts & Statistics. 5-year relative survival, 2011-2017. 2022. https://cancerstatisticscenter.cancer.org/#!/data-analysis/SurvivalByStage.

3. Kato S, Honda K. Use of biomarkers and imaging for early detection of pancreatic cancer. Cancers. 2020;12(7):1965.

4. Young MR, Abrams N, Ghosh S, Rinaudo JAS, Marquez G, Srivastava S. Prediagnostic image data, artificial intelligence, and pancreatic cancer: a tell-tale sign to early detection. Pancreas. 2020;49(7):882–6.

5. Koul A, Baxi AC, Shang R, Meng X, Li L, Keilin SA, et al. The efficacy of rapid on-site evaluation during endoscopic ultrasound-guided fine needle aspiration of pancreatic masses. Gastroenterol Rep. 2018;6(1):45–8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3